PublicationsResearchLab tools, stock lists and protocolsMembers of our labContact Us!The Biochemistry DepartmentThe Molecular Biology ProgramProtocols and stocks

Ana's Fly Stocks Inventory updated August 15, 2007

  Box # 1 : spn/Rad mutants:

Box # 2 : mapping/balancer stocks
  • •  w 1118 lig4 169 ; sco/ CyO ; TM6, Tb/MKRS (PCR 6&8 on 12/21/05)
  • •  Bloomington 1567: Df(2L)JS17
  • •  Bloomington 2382: TM2 , ry[SC]/ MKRS
  • •  Bloomington 3703: w 1118 /Dp(1;Y)y[+]; CyO pr[ cn/nub b noc[ Sco ] lt stw; MKRS/TM6B , Tb
  • •  Bloomington 7198: w[*]; Kr[If-1]/CyO; D/TM3, Ser
  • •  Bloomington 7199: w[*]; Kr[If-1]/CyO; D/TM6C, Sb Tb
  • •  Bloomington 8523 : w 1118 ; P{w[+mC]=EP} rad50 [EP1]/CyO
  • •  ru cu ca ems 7099
  • •  rad201[1]/CyO; TM6, Ubx/MKRS
  • •  sco/CyO; spnB e/ TM6, e
  • •  v-30F; TM2/MKRS
  • •  TM3, Sb / TM6, Ser, Tb
  • •  w 1118 /w+; sco/ CyO DTS513 ; TM6/MKRS
  • •  w; sco/T(2,3) SM6, TM6 ap Tb
  • •  w; sco / CyO; FlpISceI/ MKRS (Flp was not balanced, is on MKRS now)
  • •  w ; FlpISceI / CyO; TM6, Tb / MKRS
  • •  w ; FlpISceI on 2
  • •  w; FlpISceI, sco / s 2 CyO
  • •  w ; AB2 / s 2 CyO; YM1
  • •  y 1 w* H [w+ mc P ? 2-3 ] Hop8 on X
  • •  y 1 w* Sp / CyO; ? 2-3 , Sb / TM6, Ubx

Box # 3 : y Stocks

  • •  Bloomington 5269: FM7d, w oc ptg/C(1)DX, y f
  • •  w; YM1, the real YM1
  • •  yMX-4; AB2/ CyO; spnA093/TM6 vial 8.x
  • •  w1118 ; okrAG YM2/ CyO vial 2.x
  • •  w1118 ; okrAG YM2/ CyO vial 3.x
  • •  w1118; AB2/CyO; spnA093 YM1/TM6 vial 3.x
  • •  w ; FlpISceI ; spnA-093A / TM6
  • •  w1118; sco/CyO; spnA093 YM1/TM6 vial 8.x
  • •  yMX-4; AB2/ CyO; spnA093/TM6 vial 7.x
  • •  yMX-4; AB2/ CyO; spnA093/TM6 vial 6.x
  • •  w: sco/s2CyO
  • •  w ; [YM1, w+] on 3 PCR1 ok
  • •  w ; P [y M , w+] on 2 PCR1 ok
  • •  y MX--4 from Gargi
  • •  w ; AB2 / CyO; TM6/MKRS
  • •  w ; FlpISceI ; AB10 / TM3, Sb
  • •  784: FM6/C(1)DX , y[*] f[1]
  • •  TM2/MKRS
  • •  YX72
  • •  YX46 not sequenced
  • •  YX42 not sequenced
  • •  YX57
  • •  YX58  

Box # 4 : yellow spnA experiment

  • •  Bloomington 5439: w[1118]; In(2LR)Gla, wg[Gla-1] Bc[1]/CyO
  • •  Bloomington 1362: Bc[1]/CyO
  • •  Bloomington 3128: Df(3R)M-Kx1/TM3, Sb[1]
  • •  From Yikang: spnA-003
  • •  w: FlpISceI/CyO; yB ry+/Sb
  • •  yai2C; YM1/TM6, Ubx
  • •  FM7w/w; YM1/TM6, Ubx
  • •  w lig4; sco/CyO; TM6/MKRS (PCR 6&8)
  • •  w: okr-AA/CyO; FlpISceI/TM6
  • •  w; okr-AA/CyO; Flp/TM6
  • •  w; okr-AA/CyO; FlpISceI/MKRS (not balanced)
  • •  w; okr-AA YM2/CyO; AB10/TM6
  • •  w; okr-AG YM2/CyO; spnA/TM6
  • •  w; okr-AG YM2/CyO; AB10/TM6
  • •  w; okr-AG YM2/CyO; TM6/MKRS
  • •  w; AB2/CyO; spnA 093 YM1/ TM6 vials 8.x and 1.x
  • •  w; sco/CyO; spnA 093 YM1/ TM6 vials 8.x
  • •  y MX-4 ; yAB2/CyO; spnA 093 / TM6
  • •  y MX-4 ; yAB2/CyO; MKRS/ TM6

Box # 5 : 2&3 balancers = mapping stock, expanded

  • •  Bloomington 2551: CyO /noc[ Sco ]; TM6/MRS
  • •  Bloomington 3703: w 1118 /Dp(1;Y)y+; CyO pr cn/nub b noc[ Sco ] lt stw; MKRS/TM6B , Tb

  Box# 6 : TM2/MKRS stocks

  •   •  TM2/MKRS vials
  • •  w+lig4; ryAB2/CyO; spnA-093A/TM6
  • •  v; Flp IsceI, sco/CyO; ry
  • •  yw; Sp/CyO; delta 2-3, Sb/TM6, Ubx
  • •  TM3, Sb/TM6, Tb Dr
  • •  Basc; Sb/TM3, Ser
  • •  VenusDmRad51 spnA-093A/TM6 #13
  • •  VenusDmRad51 spnA-093A/TM6 #14  

Box # 7 : w+ lig4-169 variants

  • •  w+ lig4-169 variant x5
  • •  w+ lig4-169 variant x7, with partial balancers CyO, TM6(Ubx) and MRS
  • •  w+ lig4-169 variant x24
  • •  w+ lig4-169 variant x42
  • •  w+ lig4-169 variant x13
  • •  w+ lig4-169 variant x17
  • •  w+ lig4-169 variant x28
  • •  w+ lig4-169 variant x58
  • •  w+ lig4-169; Flp/CyO; +/MKRS
  • •  w+ lig4-169; sco/CyO; TM6/MKRS
  • •  w+ lig4-169; Flp/CyO; spnA/TM6
  • •  Yai2c; YM1/MKRS
  • •  Yai2c on X
  • •  yB1D on X
  • •  yB4B on 3
  • •  w; okr-AG YM2/CyO; TM6/MKRS
  • •  w+?; okr-AA?/CyO; TM6/MKRS

Box # 8 : Rad mutants and delta 2-3,99B stocks

Box # 9 : MeiW68 and Duplic. spnA on X stocks

Box # 10 : UAS-P, Gal4 stocks

Box # 11 : UASP Flp+ISceI transformants; Gal4 stocks!

  • •  w UASP ISceI -1B/FM7w
  • •  w UASP ISceI -4D/FM7w
  • •  w UASP ISceI -4E/FM7w
  • •  W; UASP ISceI -3A/CyO; TM6/MKRS/+
  • •  w; UASP ISceI -5A/CyO; +/TM6/MKRS
  • •  W; UASP ISceI -5B/CyO; TM6/+/MKRS
  • •  W; UASP ISceI -5D/CyO; TM6/MKRS
  • •  W; UASP ISceI -7A/CyO; +/MKRS
  • •  W; UASP ISceI -7B/CyO; TM6/MKRS/+
  • •  W; UASP ISceI -N /CyO; +/MKRS
  • •  W; +/CyO; UASP ISceI -4B/MKRS
  • •  W; +/CyO; UASP ISceI -6B/MKRS
  • •  W; UASP ISceI -4A/MKRS
  • •  w; sco/CyO; UASP ISceI -1A/TM6, Tb (not balanced by MKRS)
  • •  w; sco/CyO; ISceI UASP-6A/MKRS
  • •  W; sco/CyO; UASP ISceI-6C/TM6, Tb
  • •  w UASP Flp (2C) + ISceI (4E)/FM7w, #19 ok
  • •  w UASP Flp (2C) + ISceI (4E)/FM7w, #29 ok

Box # 12 : UASP/Gal4 potential recombinants

  • •  Venus DmRad51 spnA-093A /TM6 #13
  • •  W; Gal4 VP16 nos/TM6 #3
  • •  W; UASP F+I (3C)/CyO #11
  • •  W; UASP ryAB2 meiW68-1 /CyO #1, 2
  • •  W;UASP F+I meiW68-1 /CyO #1-4, 6-8

Box # 13 : C(1)DX

  • •  Bloomington 784: FM6/C(1)DX , y* f
  • •  Bloomington 5269: FM7d, w oc ptg/ C(1)DX , y f

Box # 14 : v;ry stocks

  • •  v; ry-506

Box # 15 : w stocks

  • •  w1118 bottles

Box # 16 : RNA injection

  • •  w+lig4-169 (x7) no balancers
  • •  meiP22-103 e spnA-1 (on 3 rd )